Antognolla CEO: Rising Demand for Branded Residences in Mediterranean Driven by Lifestyle Shift among High-Net-Worth Individuals
Demand for branded residences in the Mediterranean is expected to rise as high-net-worth individuals change their lifestyle preferences, says Antognolla Resort and Residences’ CEO, Federico Ricci.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250407645308/en/
Antognolla Castle - (Credit: Antognolla Resort and Residences)
Mr Ricci made his comments after attending the International Hospitality Investment Forum EMEA, held in Berlin from 31 March to 2 April. This year’s forum focused on the rapidly evolving hospitality investment landscape and the changing definition of luxury for both guests and investors.
“Discussions with other industry leaders have only reaffirmed our insights regarding the shift in the behavioural patterns of our customers,” said Mr Ricci. “This shift is more than just a passing trend; it reflects a deeper change in how people choose to live and invest in property. The pandemic accelerated the rise of remote work and proved that proximity to nature is becoming more trendy.”
Originally from Umbria, Mr Ricci has dedicated his professional life to developing the region’s economic potential through his work in both the private and public sectors. “Antognolla is among the most anticipated hospitality and residential developments not only in Umbria but also in the Mediterranean. It will offer a rare blend of traditional Italian architecture and contemporary service,” Mr Ricci added.
Mr Ricci joined Antognolla Resort and Residences in March 2025. Commenting on the appointment, Andrey Yakunin, Chairman of Antognolla’s Board of Directors, said: “We are delighted to have Federico Ricci join us as our CEO. We are confident that, with his expertise and leadership, he will play a crucial role in Antognolla’s further growth, building on the strong foundation that we have established in recent years.”
About Antognolla Resort and Residences
Antognolla Resort and Residences, currently under development, is a unique countryside resort that, upon completion, will feature a renovated 12th-century castle, turnkey residences, a 71-key hotel, and a 3,000-square-metre wellness centre alongside an award-winning 18-hole championship golf course designed by the renowned Robert Trent Jones Jr. The stunning Antognolla Castle and Old Borgo are the core of the resort. The resort’s operator, Six Senses, will introduce its signature focus on wellness and sustainability. The estate is surrounded by forests, olive trees, and vineyards and is connected to a network of natural parks.
Source: AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20250407645308/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Geoquip Marine Secures €100million Bond to Accelerate Fleet Enhancements and Strategic Growth4.4.2025 09:00:00 CEST | Press release
Use of proceeds to be split between capital expenditure to fund two ongoing projects on the Geoquip Silvretta and the Geoquip Elena vessels; general corporate purposes and repayment of existing debt Geoquip Marine (Geoquip), a global leader in offshore geotechnical solutions and a Njord Partners portfolio company, is pleased to announce today it has successfully closed a €100million bond offering. This bond issuance significantly improves the Company’s cash balance, supports its continued growth, and is seen as a significant step in the Company’s ongoing maturation and development. The bond was placed after a successful roadshow with investors and will be used to advance key strategic initiatives. The immediate use of proceeds will be allocated between the repayment of existing debt and funding for two transformational projects: The Geoquip Silvretta: As announced in December, Geoquip Silvretta is currently in a shipyard in Norway undergoing work to create a state-of-the-art geotechnic
SES Announces Annual General Meeting Voting Results4.4.2025 08:50:00 CEST | Press release
SES S.A. (“SES” or the “Company”) held the Company’s Annual General Meeting (“AGM”) at its headquarters in Betzdorf, Luxembourg, yesterday. The shareholders have voted all resolutions in accordance with the recommendations made by SES’s Board of Directors, notably the company’s 2024 annual accounts and the proposed annual dividend of EUR 0.50 per A-share (EUR 0.20 per B-share). The total amount includes the interim dividend of EUR 0.25 per A-share (EUR 0.10 per B-share) already paid to shareholders on 17 October 2024. The final dividend of EUR 0.25 per A-share (EUR 0.10 per B-share) will be paid to shareholders on 17 April 2025. Also as recommended by the Board of Directors, the shareholders approved the appointments of Mrs Ellen Lord and Mr John Shaw to the Board of Directors and the non-binding agenda item received from Atlas Infrastructure Partners regarding capital returns. “The outcome of the AGM is the result of SES’s ongoing commitment to productive shareholder engagement, ensur
ENHERTU® Approved in the EU as First HER2 Directed Therapy for Patients with HR Positive, HER2 Low or HER2 Ultralow Metastatic Breast Cancer Following at Least One Endocrine Therapy4.4.2025 08:00:00 CEST | Press release
Based on DESTINY-Breast06 phase 3 trial results which showed ENHERTU demonstrated superiority versus chemotherapy with a median progression-free survival of more than one year Approval brings Daiichi Sankyo and AstraZeneca’s ENHERTU earlier in the treatment of HR positive, HER2 low breast cancer and broadens the eligible patient population to those with HER2 ultralow disease Daiichi Sankyo (TSE: 4568) and AstraZeneca’s (LSE/STO/Nasdaq: AZN) ENHERTU® (trastuzumab deruxtecan) has been approved in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic hormone receptor (HR) positive, HER2 low (IHC 1+ or IHC 2+/ISH-) or HER2 ultralow (IHC 0 with membrane staining) breast cancer who have received at least one endocrine therapy in the metastatic setting and who are not considered suitable for endocrine therapy as the next line of treatment. ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by D
Western Union Offers Zero-Fee International Money Transfers to Myanmar4.4.2025 03:00:00 CEST | Press release
Available to consumers around the world sending money to their loved ones in Myanmar via WesternUnion.com and the Western Union app In response to the devastating earthquake that recently struck Myanmar, Western Union today announced that it is offering consumers around the world zero-fee international money transfers1 to the country. Effective immediately until midnight, 00:00 Myanmar Standard Time on 10 April 2025, individuals can send funds to Myanmar via WesternUnion.com or the Western Union mobile app, ensuring families can provide crucial support to their loved ones during this time of urgent need. Western Union remains committed to providing support during times of crisis, offering zero-fee transfers whenever possible to help communities in need. Money transfers sent to Myanmar will be: Available for payout into bank accounts. Available for payout into select mobile wallets Available for payouts incash at Agent locations2 “Our thoughts are with the people of Myanmar during this
Clean Tech Leader Aymium Defeats Stora Enso at European Patent Office Boards of Appeal4.4.2025 00:07:00 CEST | Press release
Ruling Maintains Aymium's Patent and Leading Position in Renewable Batteries and Anodes Cleantech leader Aymium defeated a challenge by Stora Enso to one of Aymium's patents (European Patent EP2697185) that provides exclusive rights to produce, sell and use bio-based materials for renewable battery applications. In its written opinion, the Boards of Appeal of the European Patent Office found Stora Enso's arguments brought before the board “not convincing” and agreed that a clarifying amendment to the claims did not extend the scope of protection of the patent. The ruling further affirms Aymium's position as the global leader in biocarbon materials for battery applications. Beyond the present ruling, Aymium owns a portfolio of more than 600 patents relating to biocarbon materials, compositions and manufacturing methods, including many specifically relevant to battery materials, and is the dominant global innovator regarding biocarbon materials. The ruling, combined with Aymium's massive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom